Search

everythinglearnresearchcommunity

for

Search:↓

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Women pay more for the same 5% minoxidil foam than men, but prices for liquid solutions are similar.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Women's facial moisturizers cost more per ounce than men's.

Gender affects wool traits in sheep, with males and females showing differences in skin proteins related to wool growth.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

India is seeing more cases of gender incongruence and changes in how it's understood and managed legally and medically.

Feminizing hormone therapy increases kidney filtration rate.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.